| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/18/2007 | CN1947772A Medicine prepn. for treating synovitis and synovial capsule cystis |
| 04/18/2007 | CN1947771A Medicine composition for treating fracture and its prepn. method |
| 04/18/2007 | CN1947768A Medicinal pillow for treating and preventing cervical spondylosis, and its prepn. method |
| 04/18/2007 | CN1947758A Medicine composition for treating rheumatosis and heumatism |
| 04/18/2007 | CN1947756A Formula of seven herbs medicine composition for relieving internal heat and invigorating blood circulation, its prepn. process and use |
| 04/18/2007 | CN1947738A Novel pharmaceutical use of total sennoside in senna, and method for preparing the same |
| 04/18/2007 | CN1947724A Compound amino-glucose hydrochloride, chondroitin sulfate effervescent, tablets prepn. method and use thereof |
| 04/18/2007 | CN1947719A Application of aspirin for preventing and treating osteoporosis |
| 04/18/2007 | CN1947715A Application of Gulunbin, iso-gulunbin and fibleucin for preparing medicine for treating arthritis |
| 04/18/2007 | CN1947695A Method for producing black mud by using sea salt as raw material |
| 04/18/2007 | CN1947693A Method for producing black mud by using well mineral salt as raw material |
| 04/18/2007 | CN1947686A Salt-solution with health-care function |
| 04/18/2007 | CN1311064C Colourless transparent health care wine for knocks and falls and its preparation method |
| 04/18/2007 | CN1310948C Modified peptides as therapeutic agents |
| 04/18/2007 | CN1310922C Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 04/18/2007 | CN1310921C Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/18/2007 | CN1310919C 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
| 04/18/2007 | CN1310906C Indole-type derivatives as inhibitors of p38 kinase |
| 04/18/2007 | CN1310900C Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing the same |
| 04/18/2007 | CN1310885C Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative |
| 04/18/2007 | CN1310870C Enantiomerically enriched 1-phenylethylamines |
| 04/18/2007 | CN1310679C Method of achieving persistent transgene expression |
| 04/18/2007 | CN1310666C Pure Chinese medicine original medicinal pad for diminishing inflammation, relieving pain and dissipating mass |
| 04/18/2007 | CN1310656C Chinese medicine prepn for treating pain in neck, shoulder, waist and leg |
| 04/17/2007 | US7205403 Preferential G protein coupled receptor antagonists, such as 8-(3-amino-1-methyl-1H-pyrazol-5-yl)-1,3-dipropyl-3,7-dihydro -1H-purine-2,6-dione, used for prophylaxis of asthma, autoimmune diseases or retinopathy |
| 04/17/2007 | US7205397 Modulatory polypeptide; for use in the treatment of bone disorders |
| 04/17/2007 | US7205386 Truncated CD200 |
| 04/17/2007 | US7205327 Benzoimidazole or imidazole-2-carbonyl)-amino)-3-methyl butyrylamino)-5-fluoro-4-oxo- derivatives |
| 04/17/2007 | US7205310 inflammatory conditions such as multiple sclerosis |
| 04/17/2007 | US7205309 Obesity therapy; administering orlistat |
| 04/17/2007 | US7205308 Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/17/2007 | US7205298 Substituted triazine kinase inhibitors |
| 04/17/2007 | US7205288 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 04/17/2007 | US7205286 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 04/17/2007 | US7205275 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 04/17/2007 | US7205151 Antiinflammatory agents; skin disorders |
| 04/17/2007 | US7205139 Expression vector comprising nucleotide sequences coding serine protease for use in diagnosis and treatment of thrombotic disorders |
| 04/17/2007 | CA2386799C Fused cycloheptane and fused azacycloheptane compounds and their as integrin receptor antagonists |
| 04/17/2007 | CA2371645C Naphtalene or heterocyclically substituted benzimidazoles as parp inhibitors |
| 04/17/2007 | CA2348725C Vitamin d analogues |
| 04/17/2007 | CA2153789C Biologically active tgf-.beta.1 and tgf-.beta.2 peptides |
| 04/12/2007 | WO2007041712A1 Pyrazolopyrimidines as protein kinase inhibitors |
| 04/12/2007 | WO2007040439A1 New compounds ii |
| 04/12/2007 | WO2007040438A2 Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders |
| 04/12/2007 | WO2007040436A1 Use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer’s disease |
| 04/12/2007 | WO2007040208A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof |
| 04/12/2007 | WO2007039470A1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 04/12/2007 | WO2007038943A1 Y2 selective receptor agonists for therapeutic interventions |
| 04/12/2007 | WO2007023115A3 P38 map kinase inhibitors and methods for using the same |
| 04/12/2007 | WO2007023115A2 P38 map kinase inhibitors and methods for using the same |
| 04/12/2007 | WO2007017264A3 Pyrrolopyridinederivatives as modulators of the cannabinoid receptor for the treatment of immune and inflammatory disorders |
| 04/12/2007 | WO2007016240A3 Use of antibody to m-csf |
| 04/12/2007 | WO2007014639A3 Method for isolating stem cells from cryopreserved dental tissue |
| 04/12/2007 | WO2007003421A3 Humanised antibodies specific for nogo-a and pharmaceutical uses thereof |
| 04/12/2007 | WO2006120007A3 Production of glucosamine from plant species |
| 04/12/2007 | WO2006041670A3 Uv device for treating osteolysis |
| 04/12/2007 | US20070082957 2-chloro-5-(3-oxopropyl)-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-benzamide; P2X7 receptor antagonists; inflammatory, immune or cardiovascular diseases |
| 04/12/2007 | US20070082930 Pharmaceutical composition comprising a p2x7 receptor antagonist and a nonsteroidal anti-inflammatory drug |
| 04/12/2007 | US20070082912 Pyrrole compounds for the treatment of prostaglandine mediated diseases |
| 04/12/2007 | US20070082903 Remedy for rheumatoid arthritis |
| 04/12/2007 | US20070082897 Acylated indanyl amines and their use as pharmaceuticals |
| 04/12/2007 | US20070082871 Antiresorptive mutual salt of raloxifene and bisphosphonic acid |
| 04/12/2007 | US20070081991 Compositions and methods for modulation of immune responses |
| 04/12/2007 | US20070081974 Antibody targeting osteoclast-associated protein |
| 04/12/2007 | DE102005048293A1 Retardformulierung für Pralnacasan Sustained-release formulation pralnacasan |
| 04/12/2007 | CA2624882A1 Pyrazolopyrimidines as protein kinase inhibitors |
| 04/12/2007 | CA2624869A1 New compounds ii |
| 04/12/2007 | CA2624649A1 Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders |
| 04/12/2007 | CA2623813A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof |
| 04/12/2007 | CA2623094A1 Y2 selective receptor agonists for therapeutic interventions |
| 04/12/2007 | CA2621040A1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 04/11/2007 | EP1772150A1 Benzothiophene formulations of a specific dosage |
| 04/11/2007 | EP1771470A2 Actrii receptor polypeptides, methods and compositions |
| 04/11/2007 | EP1771200A1 Physiologically-active composition based on collagen |
| 04/11/2007 | EP1771195A1 Pharmaceutical composition comprising botulinum toxin for treating knee joint pain by saphenous nerve entrapment |
| 04/11/2007 | EP1771181A2 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 04/11/2007 | EP1771178A1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies |
| 04/11/2007 | EP1771166A2 Rxr antagonists in the treatment of inflammatory diseases |
| 04/11/2007 | EP1511759A4 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof. |
| 04/11/2007 | EP1392641B1 Substituted cyclohexane-1,4-diamine derivatives |
| 04/11/2007 | EP1341767B1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 04/11/2007 | EP0988379B1 Ldl-receptor |
| 04/11/2007 | EP0950656B1 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 04/11/2007 | EP0787122B1 Calcium receptor-active compounds |
| 04/11/2007 | CN1946743A Hyaluronic acid/methotrexate compound |
| 04/11/2007 | CN1946707A Dibenzo chromene derivatives and their use as ERbeta selective ligands |
| 04/11/2007 | CN1946395A 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors |
| 04/11/2007 | CN1944433A 3-ene-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid amino acid amide, its synthetic method and light power therapeutic medicine |
| 04/11/2007 | CN1944432A 3-(1-alkoxy ethyl)-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid, its synthetic method and light power therapeutic medicine |
| 04/11/2007 | CN1944420A Iguratimod crystal form and its composition |
| 04/11/2007 | CN1943781A Orally administered peptides to ameliorate atherosclerosis |
| 04/11/2007 | CN1943775A A kind of pharmaceutical for treatment of arthritis |
| 04/11/2007 | CN1943758A A Chinese traditional medicinal composition for treatment of rheumatism and its preparation method |
| 04/11/2007 | CN1943703A Battlefield appeasing capsules and their preparation method |
| 04/11/2007 | CN1943700A A Chinese traditional medicinal preparation for treatment of eczema |
| 04/11/2007 | CN1943691A A Chinese traditional medicinal composition for treatment of osteoporosis and its preparation method |
| 04/11/2007 | CN1943688A A Chinese traditional medicinal composition for treatment of necrosis of head of femur and its preparation method |
| 04/11/2007 | CN1943687A A Chinese traditional medicinal composition for treatment of prolapse of lumbar intervertebral disc and its preparation method |
| 04/11/2007 | CN1943673A Sedation brain refreshing liquid |
| 04/11/2007 | CN1943651A A medicinal composition for treating gout |